Bleeding Events After Triple Antithrombotic Therapy Initiation.

Bleeding Events After Triple Antithrombotic Therapy Initiation: a Prospective Observational Study in Real Life

The optimal antithrombotic therapy for patients requiring anticoagulation after coronary stenting is unknown. Double platelets suppressive agents combined with oral anticoagulation (triple antithrombotic therapy) remains the Gold standard.

Our study aims at studying bleeding events occurring until 6 months after the initiation of triple antithrombotic therapy.

Inclusion Criteria:

• patients requiring triple antithrombotic therapy, including double antiplatelets agents and oral anticoagulation

Exclusion Criteria:

• history of bleeding
• patients already under triple antithrombotic therapy
• patients under vitamin K antagonists